Adolescents and adults born during or since 1966 are recommended to have received 2 doses of mumps-containing vaccine

All adolescents and adults born during or since 1966 should have either:

• documented evidence of 2 doses of mumps-containing vaccine given at least 4 weeks apart and with both doses given at ≥12 months of age, or
• serological evidence of immunity to measles, mumps and rubella

See also Serological testing for immunity to mumps.

Adolescents and adults who have been incompletely vaccinated or do not have evidence of immunity to mumps are recommended to receive mumps-containing vaccine. See Catch-up vaccination for more details, including minimum intervals between doses.

Review vaccination records for all adolescents and young adults to ensure that they have received 2 doses of mumps-containing vaccine. See Epidemiology.

Mumps-containing vaccine is funded through the NIP for adolescents and adults aged <20 years who have been incompletely vaccinated or do not have evidence of immunity to mumps. For details see the National Immunisation Program Schedule.

Adolescents and adults who are at risk of acquiring mumps during an outbreak can receive a 3rd dose of mumps-containing vaccine to maintain protection.

People aged ≥14 years are not recommended to receive MMRV vaccine

MMRV vaccine is not recommended for use in people ≥14 years of age. No data are available on safety, immunogenicity or efficacy in this age group.

If a person ≥14 years of age is inadvertently given a dose of MMRV vaccine, this dose does not need to be repeated.